Juventas Closes Series B

Cleveland, OH- based Juventas Therapeutics, a clinical-stage regenerative medicine company, has closed a $22.2 million Series B financing that was co-led by Triathlon Medical Venture Partners and New Science Ventures. All previous venture firms, including Fletcher Spaght Ventures, Reservoir Venture Partners and Early Stage Partners participated in the round. Also joining the syndicate are new […]

USVP Backs LineStream Technologies

LineStream Technologies, a software-based control solutions provider, has closed a Series B funding round led by U.S. Venture Partners, joining Series A investor Early Stage Partners. Winston Fu, general partner, and David Liddle, venture partner, of USVP have joined the company’s board of directors. PRESS RELEASE LineStream Technologies Inc., an innovator of software-based control solutions, […]

OnShift Inks $3M Series B

OnShift, a maker of web-based staff scheduling and shift management software for healthcare companies, has closed a $3 million Series B round. The round is led by a client of West Capital Advisors and included participation from OnShift’s institutional investors Draper Triangle Ventures, Early Stage Partners and Glengary, the company said in a statement.

CytoPherx Seals $34M

CytoPherx Inc., a developer of anti-inflammatory therapy for acute kidney injury, has raised $34 million in funding from Early Stage Partners, ONSET Ventures and Capital Midwest Fund. The money will be used to complete clinical trials and commercialize its therapy product. CytoPherx was founded in July 2007 and is based in Ann Arbor, Michigan.

PE HUB Community

Join the 12523 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget